Stay updated on Pembrolizumab in Advanced Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Urothelial Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Urothelial Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page revision tag was updated from v3.5.2 to v3.5.3. This signals a minor update to the page version rather than a change to visible content.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2, replacing the previous revision.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. No change to study details or page content.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.1%

- Check91 days agoChange DetectedRevision: v3.4.2 was added, and a prior revision notice (v3.4.1) along with a government funding status notice were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check98 days agoChange DetectedAdded a government funding lapse notice about NIH operations and updated the page revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab in Advanced Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Urothelial Cancer Clinical Trial page.